Using CBA antibodies targeting MOG have been recently identified in both children and adults with demyelination disorders including acute disseminated encephalomyelitis (ADEM), optic neuritis (ON), transverse myelitis (TM), and AQP4-seronegative NMOSD [124]. This evidence concerns the gene MOG and optic neuritis.